BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) announced today that...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
KING PHARMACEUTICALS (KG)
King Pharmaceuticals, Inc. is the world’s 39th-largest pharmaceutical company. It provides branded prescription pharmaceutical products worldwide It primarily offers branded prescription products for primary care physicians, neurologists, orthopedic surgeons, hospitals, internal medicine physicians, allergists, pediatricians, and pain specialists. Some brands include Altace for heart attack prevention; Levoxyl for hypothyroidism; Sonata for sleeping; and Skelaxin, a muscle relaxant.
King Pharmaceuticals (KG) is part of Business Exchange, suggested by
Ginny Moore.
This topic contains
133 news
and
95 blog
items.
Read updated news, blogs, and resources about King Pharmaceuticals (KG). Find user-submitted articles and reactions on King Pharmaceuticals (KG) from
like-minded professionals.
Blogs
Please add new articles to this topic
...its website a warning letter send to King Pharmaceuticals over two Embeda video news releases. The letter is below.
WASHINGTON, Oct 20 (Reuters) - Two video news releases for King Pharmaceuticals' (KG.N) pain drug Embeda left out a...
King Pharmaceuticals, Inc. announced today that the U.S. Food and Drug...
Information on King Pharmaceuticals company » notizia originale...
King Pharmaceuticals (NYSE: KG) opened at $10.36. So far today, the stock has hit a low of $10.32 and a high of $10.52.
King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the...
Why is King hiring new sales reps externally instead of rehiring the recently laid off reps???
...find out what King Pharmaceuticals CEO said to Fast Money. Read More ... Topics:Stock Market | Stock Picks.
Though CP rumor mill, saw thread on JNJ site said it was interested in buying King.
You'll not have to ask a lot of questions other than where it can be further applied continuing with OXY-NT which came...
The Food and Drug Administration made King Pharmaceuticals (NYSE: KG) wait an extra...
Acura Pharmaceuticals Inc (Nasdaq:ACUR) and King Pharmaceuticals Inc (NYSE:KG) declared on Thursday that the...
BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) today announced plans...
PennyStockChaser.com is pleased to offer a hot stock alerts service.
The drug company is up in after-hours trading following heavy options activity. One possible catalyst could be a new...
King Pharmaceuticals (KG) was upgraded today by analysts at Goldman Sachs and the stock is now at $6.91, up $0.18 (2.
NEW YORK, Feb 26 (Reuters) - King Pharmaceuticals Inc (KG.N) posted a fourth-quarter loss on Thursday on a big charge...
The firm King Pharmaceuticals, has decided to go for King Pharmaceuticals Lay offs or King Pharmaceuticals Job Cuts.
Top Sources: King Pharmaceuticals (KG)
- Finance, Investments n Trading
- BioSpace.com Featured News
- Cafepharma Message Boards
- 10Q Detective
- BlogNetNews.com » Tennessee
- M2 PressWIRE: Latest Headlines
- MarketIntelligenceCenter.com
- optionMONSTER News
- Pharma Analysis RSS | BNET Industries
- Latest articles from PRWeek US News
Most Active Users in this Topic
No user contributions
account